4-[[(3aR,5aR,5bR,9S,11aR,11bS,13aS)-3a-[[5-(5-chloro-2-pyridinyl)-1,3,4-oxadiazol-2-yl]amino]-5a,5b,8,8,11a-pentamethyl-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3H-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid

C42H57ClN4O6 — CID 138456486

IUPAC4-[[(3aR,5aR,5bR,9S,11aR,11bS,13aS)-3a-[[5-(5-chloro-2-pyridinyl)-1,3,4-oxadiazol-2-yl]amino]-5a,5b,8,8,11a-pentamethyl-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3H-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid
SMILESCC(C)C1=C2[C@H]3CC[C@H]4[C@@]5(C)CC[C@H](OC(=O)CC(C)(C)C(=O)O)C(C)(C)C5CC[C@@]4(C)[C@]3(C)CC[C@@]2(Nc2nnc(-c3ccc(Cl)cn3)o2)CC1=O
InChIInChI=1S/C42H57ClN4O6/c1-23(2)32-27(48)20-42(45-36-47-46-34(53-36)26-12-10-24(43)22-44-26)19-18-40(8)25(33(32)42)11-13-29-39(7)16-15-30(52-31(49)21-37(3,4)35(50)51)38(5,6)28(39)14-17-41(29,40)9/h10,12,22-23,25,28-30H,11,13-21H2,1-9H3,(H,45,47)(H,50,51)/t25-,28?,29+,30+,39+,40-,41-,42-/m1/s1
InChIKeyVERGBDGJPQCYMW-LDPXRDPBSA-N
MW749.39 g/mol
LogP9.34
Rot. Bonds8

About 4-[[(3aR,5aR,5bR,9S,11aR,11bS,13aS)-3a-[[5-(5-chloro-2-pyridinyl)-1,3,4-oxadiazol-2-yl]amino]-5a,5b,8,8,11a-pentamethyl-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3H-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid

4-[[(3aR,5aR,5bR,9S,11aR,11bS,13aS)-3a-[[5-(5-chloro-2-pyridinyl)-1,3,4-oxadiazol-2-yl]amino]-5a,5b,8,8,11a-pentamethyl-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3H-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid (PubChem CID 138456486) has the molecular formula C42H57ClN4O6 and a molecular weight of 749.39 g/mol. Its IUPAC name is 4-[[(3aR,5aR,5bR,9S,11aR,11bS,13aS)-3a-[[5-(5-chloro-2-pyridinyl)-1,3,4-oxadiazol-2-yl]amino]-5a,5b,8,8,11a-pentamethyl-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3H-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid.

Molecular Properties

Compound Name4-[[(3aR,5aR,5bR,9S,11aR,11bS,13aS)-3a-[[5-(5-chloro-2-pyridinyl)-1,3,4-oxadiazol-2-yl]amino]-5a,5b,8,8,11a-pentamethyl-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3H-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid
PubChem CID138456486
Molecular FormulaC42H57ClN4O6
Molecular Weight749.39 g/mol
Exact Mass748.40
IUPAC Name4-[[(3aR,5aR,5bR,9S,11aR,11bS,13aS)-3a-[[5-(5-chloro-2-pyridinyl)-1,3,4-oxadiazol-2-yl]amino]-5a,5b,8,8,11a-pentamethyl-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3H-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid
SMILESCC(C)C1=C2[C@H]3CC[C@H]4[C@@]5(C)CC[C@H](OC(=O)CC(C)(C)C(=O)O)C(C)(C)C5CC[C@@]4(C)[C@]3(C)CC[C@@]2(Nc2nnc(-c3ccc(Cl)cn3)o2)CC1=O
InChIInChI=1S/C42H57ClN4O6/c1-23(2)32-27(48)20-42(45-36-47-46-34(53-36)26-12-10-24(43)22-44-26)19-18-40(8)25(33(32)42)11-13-29-39(7)16-15-30(52-31(49)21-37(3,4)35(50)51)38(5,6)28(39)14-17-41(29,40)9/h10,12,22-23,25,28-30H,11,13-21H2,1-9H3,(H,45,47)(H,50,51)/t25-,28?,29+,30+,39+,40-,41-,42-/m1/s1
InChIKeyVERGBDGJPQCYMW-LDPXRDPBSA-N
XLogP9.34
TPSA144.51 Ų
H-Bond Donors2
H-Bond Acceptors9
Rotatable Bonds8
Heavy Atoms53
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500749.39
LogP ≤ 59.34
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 109

Analyze 4-[[(3aR,5aR,5bR,9S,11aR,11bS,13aS)-3a-[[5-(5-chloro-2-pyridinyl)-1,3,4-oxadiazol-2-yl]amino]-5a,5b,8,8,11a-pentamethyl-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3H-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 4-[[(3aR,5aR,5bR,9S,11aR,11bS,13aS)-3a-[[5-(5-chloro-2-pyridinyl)-1,3,4-oxadiazol-2-yl]amino]-5a,5b,8,8,11a-pentamethyl-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3H-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid?
The IUPAC name of 4-[[(3aR,5aR,5bR,9S,11aR,11bS,13aS)-3a-[[5-(5-chloro-2-pyridinyl)-1,3,4-oxadiazol-2-yl]amino]-5a,5b,8,8,11a-pentamethyl-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3H-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid (CID 138456486) is 4-[[(3aR,5aR,5bR,9S,11aR,11bS,13aS)-3a-[[5-(5-chloro-2-pyridinyl)-1,3,4-oxadiazol-2-yl]amino]-5a,5b,8,8,11a-pentamethyl-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3H-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid.
What is the SMILES notation for 4-[[(3aR,5aR,5bR,9S,11aR,11bS,13aS)-3a-[[5-(5-chloro-2-pyridinyl)-1,3,4-oxadiazol-2-yl]amino]-5a,5b,8,8,11a-pentamethyl-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3H-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid?
The canonical SMILES for 4-[[(3aR,5aR,5bR,9S,11aR,11bS,13aS)-3a-[[5-(5-chloro-2-pyridinyl)-1,3,4-oxadiazol-2-yl]amino]-5a,5b,8,8,11a-pentamethyl-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3H-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid is CC(C)C1=C2[C@H]3CC[C@H]4[C@@]5(C)CC[C@H](OC(=O)CC(C)(C)C(=O)O)C(C)(C)C5CC[C@@]4(C)[C@]3(C)CC[C@@]2(Nc2nnc(-c3ccc(Cl)cn3)o2)CC1=O.
What is the InChIKey of 4-[[(3aR,5aR,5bR,9S,11aR,11bS,13aS)-3a-[[5-(5-chloro-2-pyridinyl)-1,3,4-oxadiazol-2-yl]amino]-5a,5b,8,8,11a-pentamethyl-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3H-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid?
The InChIKey is VERGBDGJPQCYMW-LDPXRDPBSA-N. The full InChI is InChI=1S/C42H57ClN4O6/c1-23(2)32-27(48)20-42(45-36-47-46-34(53-36)26-12-10-24(43)22-44-26)19-18-40(8)25(33(32)42)11-13-29-39(7)16-15-30(52-31(49)21-37(3,4)35(50)51)38(5,6)28(39)14-17-41(29,40)9/h10,12,22-23,25,28-30H,11,13-21H2,1-9H3,(H,45,47)(H,50,51)/t25-,28?,29+,30+,39+,40-,41-,42-/m1/s1.
What are the key properties of 4-[[(3aR,5aR,5bR,9S,11aR,11bS,13aS)-3a-[[5-(5-chloro-2-pyridinyl)-1,3,4-oxadiazol-2-yl]amino]-5a,5b,8,8,11a-pentamethyl-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3H-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid?
4-[[(3aR,5aR,5bR,9S,11aR,11bS,13aS)-3a-[[5-(5-chloro-2-pyridinyl)-1,3,4-oxadiazol-2-yl]amino]-5a,5b,8,8,11a-pentamethyl-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3H-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid has a molecular weight of 749.39 g/mol, XLogP of 9.34, 8 rotatable bonds, 2 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[[(3aR,5aR,5bR,9S,11aR,11bS,13aS)-3a-[[5-(5-chloro-2-pyridinyl)-1,3,4-oxadiazol-2-yl]amino]-5a,5b,8,8,11a-pentamethyl-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3H-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid is sourced from PubChem (CID 138456486), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).